Phase II multi-institutional prospective randomised trial comparing S-1+paclitaxel with S-1+cisplatin in patients with unresectable and/or recurrent advanced gastric cancer

BACKGROUND: A combination of S-1 and cisplatin has been shown to be effective with acceptable safety for the first-line treatment of far-advanced gastric cancer in Japan. This is the first randomised phase II trial to compare S-1+paclitaxel with S-1+cisplatin in this setting. METHODS: Patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Mochiki, E, Ogata, K, Ohno, T, Toyomasu, Y, Haga, N, Fukai, Y, Aihara, R, Ando, H, Uchida, N, Asao, T, Kuwano, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389419/
https://www.ncbi.nlm.nih.gov/pubmed/22617130
http://dx.doi.org/10.1038/bjc.2012.222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389419/
https://www.ncbi.nlm.nih.gov/pubmed/22617130
http://dx.doi.org/10.1038/bjc.2012.222

Ejemplares similares